Wills Sharifia, Cabanlit Maricel, Bennett Jeff, Ashwood Paul, Amaral David G, Van de Water Judy
Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, 451 E. Health Sciences Drive, Suite 6510 GBSF, Davis, CA 95616, USA.
Brain Behav Immun. 2009 Jan;23(1):64-74. doi: 10.1016/j.bbi.2008.07.007. Epub 2008 Jul 30.
Autism spectrum disorders (ASD) are a group of heterogeneous, behaviorally defined disorders characterized by disturbances in social interaction and communication, often with repetitive and stereotyped behavior. Previous studies have described the presence of antibodies to various neural proteins in autistic individuals as well as post-mortem evidence of neuropathology in the cerebellum. We examined plasma from children with ASD, as well as age-matched typically developing controls, for antibodies directed against human cerebellar protein extracts using Western blot analysis. In addition, the presence of cerebellar specific antibodies was assessed by immunohistochemical staining of sections from Macaca fascicularis monkey cerebellum. Western blot analysis revealed that 13/63 (21%) of subjects with ASD possessed antibodies that demonstrated specific reactivity to a cerebellar protein with an apparent molecular weight of approximately 52 kDa compared with only 1/63 (2%) of the typically developing controls (p=0.0010). Intense immunoreactivity, to what was determined morphologically to be the Golgi cell of the cerebellum, was noted for 7/34 (21%) of subjects with ASD, compared with 0/23 of the typically developing controls. Furthermore, there was a strong association between the presence of antibodies reactive to the 52 kDa protein by Western blot with positive immunohistochemical staining of cerebellar Golgi cells in the ASD group (r=0.76; p=0.001) but not controls. These studies suggest that when compared with age-matched typically developing controls, children with ASD exhibit a differential antibody response to specific cells located in the cerebellum and this response may be associated with a protein of approximately 52 kDa.
自闭症谱系障碍(ASD)是一组异质性的、行为学定义的疾病,其特征为社交互动和沟通障碍,常伴有重复刻板行为。既往研究描述了自闭症个体中存在针对各种神经蛋白的抗体,以及小脑神经病理学的尸检证据。我们使用蛋白质印迹分析检测了自闭症儿童以及年龄匹配的正常发育对照儿童的血浆中针对人小脑蛋白提取物的抗体。此外,通过对食蟹猴小脑切片进行免疫组织化学染色评估小脑特异性抗体的存在情况。蛋白质印迹分析显示,63名自闭症受试者中有13名(21%)拥有对一种表观分子量约为52 kDa的小脑蛋白表现出特异性反应的抗体,而在正常发育对照中只有1/63(2%)(p=0.0010)。在34名自闭症受试者中有7名(21%)对经形态学确定为小脑高尔基细胞的结构呈现强烈免疫反应,而正常发育对照的23名受试者中无此情况。此外,在自闭症组中,蛋白质印迹检测到对52 kDa蛋白有反应的抗体的存在与小脑高尔基细胞免疫组织化学染色阳性之间存在强关联(r=0.76;p=0.001),而在对照组中无此关联。这些研究表明,与年龄匹配的正常发育对照相比,自闭症儿童对位于小脑中的特定细胞表现出不同的抗体反应,且这种反应可能与一种约52 kDa的蛋白质有关。